Release time:2020-11-20 | Click rate:
On November 19, the Ceremony for “2020 High Quality Development Forum for Listed Companies and the 22nd Golden Bull Award for Listed Companies”, jointly sponsored by China Securities Journal and Haikou Municipal People's Government, was held in Haikou, where Zhifei was awarded the 2019 Most Valuable Investment Award and Qin Fei, Secretary of the Board of Directors, was awarded the 2019 Golden Bull Director Secretary Award.
As a large backbone enterprise in domestic vaccine industry, Zhifei has always adhered to the enterprise vision of “Social benefits go before corporate profits”, insisted on independent innovation, increased R&D investment, strengthened quality management, deeply cultivated vaccine field, and successively introduced more than ten kinds of high-quality vaccine products into the market, bringing good news for people's health. This year, in the face of the severe challenges brought by COVID-19, Zhifei has seized the opportunity in the crisis to achieve positive growth in its business performance, and achieved a profit of RMB 11.05 billion in the third quarter, with an increase of 44.14% year-on-year and with full amount of tax of RMB 1.5 billion. At the same time, Qin Fei, Secretary of the Board of Directors of Zhifei, actively promotes the innovative development of listed companies by virtue of his diligence and responsibility, and has been awarded the gold medal of the secretary of the board for many times, winning widespread respect and praise from the society and investors.
This award is not only the full affirmation of Zhifei's development achievements from all sectors of life, but also represents that the majority of investors are full of expectation and confidence in the future development prospect of Zhifei. In the future, Zhifei will continue to adhere to innovation and high-quality development, create more benefits for the society and create greater value for all shareholders!